2025

A13

Entrant

Shenzhen Jamr Technology Co., Ltd.

Category

Provider & Services - Healthcare

Client's Name

Country / Region

China

The design philosophy of A13 is rooted in the principle of "bringing cutting-edge technology back to the essence of daily life." We understand that true care is not about the accumulation of technology, but about making it serve people in the simplest and most compassionate way. A13 is dedicated to breaking down the barrier between professional medical devices and home users, translating complex physiological signals into clear health guidance. Its goal is to ensure every measurement is accurate, every interaction is simple and pleasant, and every alert is timely and effective, thereby empowering every family to proactively manage their own cardiovascular health.
A13 utilizes Constant Pressure Technology to avoid the discomfort of repeated pressurization common in traditional devices, making the measurement process smooth and efficient. In addition to accurately displaying systolic, diastolic, and pulse data, it innovatively integrates Pulse Pressure Analysis, helping users assess arterial elasticity from a new dimension. This upgrades the experience from simply "measuring blood pressure" to "assessing vascular health." By integrating the core functions of a blood pressure monitor and a heart monitor into a single device, it not only saves costs but also simplifies the consolidation and tracking of long-term health data.
Equipped with a new-generation heart detection algorithm, A13 stably captures signals within the golden pressure window of 100±20 mmHg (fluctuation ≤±5 mmHg) to detect faint and intermittent abnormal pulses often missed by conventional methods, making it more sensitive for Atrial Fibrillation (AFib) screening. Its unique dual-adaptive mechanism for time and pressure matches the most comfortable pressure level for each user (especially the elderly), balancing both comfort and data accuracy. The Constant Pressure Technology ensures a smooth and efficient detection process by avoiding repeated pressurization. Furthermore, it employs a rigorous triple-measurement mode focused on screening for AFib risk and records the number of irregular pulses, providing a dynamic reference for heart health.

Credits

Tan Wenlong
Hu Yitao
Wei Lina
Outstanding Healthcare Achievements
2025
Next-Generation AI Health Platform: Eva, Healthcare Awards Winner

Entrant

Everlywell

Category

Outstanding Healthcare Achievements - Outstanding Leader in Technology Solutions

Country / Region

United States

Video, Commercial & Film
2025
Advanced Imaging for Prostate Cancer Series, Healthcare Awards Winner

Entrant

Urology Care Foundation

Category

Video, Commercial & Film - Educational

Country / Region

United States

Marketing Campaign
2025
Health is Wealth, Healthcare Awards Winner

Entrant

Medmark Marketing Agency

Category

Marketing Campaign - Branding Strategy Campaign

Country / Region

United States

Social Media
2025
#TouchMyCancer, Healthcare Awards Winner

Entrant

SERVICEPLAN GERMANY

Category

Social Media - Community

Country / Region

Germany